Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Gross Profit (2009 - 2026)

Updated

Immucell (ICCC) reported Gross Profit of $3.56 million for Q3 2026, up 50.4% from $2.36 million a year earlier and up 45.9% from the prior quarter.

Analysis

Immucell (ICCC) Gross Profit (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Immucell's Gross Profit came in at $13.56 million, up 19.3% year-over-year; for FY2025, it came in at $11.45 million, up 44.1% from FY2024.

  • Gross Profit has a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
  • By year, Gross Profit came in at $7.94 million in FY2024 (+105.2%), $3.87 million in FY2023 (-49.4%), $7.65 million in FY2022 (-11.6%) and $8.66 million in FY2021 (+26.1%).
  • Five-year quarterly Gross Profit spans a low of $300,775 in Q1 2023 and a high of $4.66 million in Q1 2026.
  • Year over year, Gross Profit gained in six of the last seven quarters, with growth averaging 43.3%.
  • The high point for year-over-year Gross Profit in five years was Q1 2024 (growth of 663.1%); the low point was Q1 2023 (a decline of 90.3%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $2.44 million (Q2 2026), $4.66 million (Q1 2026) and $2.91 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.56 Mn
Jun 30, 2026 2.44 Mn
Mar 31, 2026 4.66 Mn
Dec 31, 2025 2.91 Mn
Sep 30, 2025 2.36 Mn
Jun 30, 2025 2.82 Mn
Mar 31, 2025 3.35 Mn
Dec 31, 2024 2.83 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 1.23 Mn
Mar 31, 2024 2.30 Mn
Sep 30, 2023 1.27 Mn
Jun 30, 2023 1.04 Mn
Mar 31, 2023 300,775.00
Dec 31, 2022 992,176.00
Sep 30, 2022 1.85 Mn
Jun 30, 2022 1.71 Mn
Mar 31, 2022 3.10 Mn
Dec 31, 2021 2.56 Mn
Sep 30, 2021 2.42 Mn
API Access

Immucell Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=ICCC&period=max&api_key=YOUR_API_KEY